Lv81
7940 积分 2021-03-27 加入
Nivolumab-induced Stevens-Johnson syndrome: Not only due to PD-1 inhibition
1年前
已完结
CutaneousStevensJohnson-ToxicEpidermalNecrolysisImmunotherapyrelatedToxicitiesinLungCancerPatients
1年前
已完结
Toxic epidermal necrolysis associated with chemoimmunotherapy for lymphoma: case report and literature review
1年前
已完结
Cutaneous adverse events caused by immune checkpoint inhibitors
1年前
已完结
Lichenoid dermatitis following PD-1 inhibitor-induced toxic epidermal necrolysis: a case report and literature review
1年前
已完结
Adverse cutaneous toxicities by PD-1/PD-L1 immune checkpoint inhibitors: pathogenesis, treatment, and surveillance
1年前
已完结
Bullous pemphigoid associated with Grover disease: a specific toxicity of anti-PD-1 therapies?
3年前
已完结
Anti-PD1 immune checkpoint inhibitor-induced bullous pemphigoid in metastatic melanoma and non-small cell lung cancer
3年前
已完结
Bullous Pemphigoid Associated With a New Combination Checkpoint Inhibitor Immunotherapy
3年前
已关闭
皖公网安备34019202002308
